NiKem Research Details

NiKem Research

Company Profile:
NiKem Research is a pre-clinical service provider with around 20 clients in Europe and the US, spanning from small biotechs to big pharmas. Our people, technology platform and skills put us amongst the highest quality, reliable providers. Our usual business model is fee for service, no milestone payments or royalties, with clients owning all generated IP and results. Alternatively, we can offer either a risk sharing relationship, milestone payments to NiKem; significantly lower FTE prices, or mixed team services, routinely operations outsourced to reliable low cost providers, challenging operations performed at NiKem, IP-sensitive information contained at NiKem, significantly lower FTE prices.

Previous Clients:
Wyeth (US), Intermune (US), GSK (UK-I), Nycomed (D), Jado Labs (D), Servier (F), Idenix (F), Hybrigenics (F), Crystax (E), Addex (CH), Polichem (CH), Neurotune (CH), Athelas (CH), Alchemia (Australia), Chiesi (I), Dompè (I), Newron (I), Genextra (I), Rottapharm (I), Brane Discovery (I), Recordati (I), Italfarmaco (I), NeED Pharma (I)

Key Products:
Our platform covers discovery to pre-clinical development, and is offered as an integrated package, or as single modules. Key areas of expertise are medicinal, analytical and computational chemistry; in vitro biochemical pharmacology and early ADMET characterisation; and in vivo PK, including our recently established GLP lab. Our descriptors are the cost effectiveness of our services, the flexibility of our operations to accommodate each client's needs, the teamwork attitude of our skilled staff, and the attention to protect clients IP-sensitive data. Our management has 20 years experience (GSK), and our staff have ten years of hands on experience.

Website:
www.nikemresearch.com